Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

855
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
855
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

963
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
963
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

1.4K
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.4K
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

1.2K
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.2K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

1.0K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
1.0K
Feces Formation and Defecation01:26

Feces Formation and Defecation

5.3K
After spending 3 to 10 hours in the large intestine, chyme loses a lot of water and becomes feces, the final product of digestion. Feces consist of undigested dietary fiber such as cellulose, mucus, sloughed-off epithelial cells, and microbes. The descending and sigmoid colon stores feces and uses haustral contractions to dry it out but retains enough water to give it a semi-solid texture.
The mass peristalsis then pushes the feces into the rectum, which stretches the rectal walls to activate...
5.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Micronutrient levels in the cord blood of term neonates and its association with oxidative stress and neonatal anthropometry: a cross sectional study.

La Clinica terapeutica·2026
Same author

Association of serum vitamin E levels with oxidative stress in a pediatric intensive care unit in coastal South India: A cross sectional study.

La Clinica terapeutica·2025
Same author

Retraction notice to "Cellulase production through solid-state tray fermentation, and its use for bioethanol from sorghum stover" [Bioresource Technol. 242 (2017) 265-271].

Bioresource technology·2024
Same author

Survival bias may explain the appearance of the obesity paradox in hip fracture patients.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021
Same author

Cross-country transport and isolation and identification of <i>Streptococcus pneumoniae</i> by use of alternate sources of blood supplemented media among laboratories in India.

Indian journal of medical microbiology·2020
Same author

A high-resolution anorectal manometry parameter based on integrated pressurized volume: A study based on 204 male patients with constipation and 26 controls.

Neurogastroenterology and motility·2018

Related Experiment Video

Updated: Mar 24, 2026

A Vibrotactile Feedback Device for Seated Balance Assessment and Training
09:13

A Vibrotactile Feedback Device for Seated Balance Assessment and Training

Published on: January 20, 2019

6.9K

Biofeedback therapy for dyssynergic (obstructive) defecation

S S Rao

    Journal of Clinical Gastroenterology
    |March 24, 2000
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Real-time fMRI Biofeedback Targeting the Orbitofrontal Cortex for Contamination Anxiety
    10:51

    Real-time fMRI Biofeedback Targeting the Orbitofrontal Cortex for Contamination Anxiety

    Published on: January 20, 2012

    21.9K
    The use of Biofeedback in Clinical Virtual Reality: The INTREPID Project
    06:52

    The use of Biofeedback in Clinical Virtual Reality: The INTREPID Project

    Published on: November 12, 2009

    15.8K

    Related Experiment Videos

    Last Updated: Mar 24, 2026

    A Vibrotactile Feedback Device for Seated Balance Assessment and Training
    09:13

    A Vibrotactile Feedback Device for Seated Balance Assessment and Training

    Published on: January 20, 2019

    6.9K
    Real-time fMRI Biofeedback Targeting the Orbitofrontal Cortex for Contamination Anxiety
    10:51

    Real-time fMRI Biofeedback Targeting the Orbitofrontal Cortex for Contamination Anxiety

    Published on: January 20, 2012

    21.9K
    The use of Biofeedback in Clinical Virtual Reality: The INTREPID Project
    06:52

    The use of Biofeedback in Clinical Virtual Reality: The INTREPID Project

    Published on: November 12, 2009

    15.8K